Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants - Wikidata - thesis-toulmin - TriplyDB

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

http://www.wikidata.org/entity/Q33988269

about

Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children.Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts.The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review.Quality of 186 child brain spectra using motion and B0 shim navigated single voxel spectroscopy.Comparison of traditional culture and molecular qPCR for detection of simultaneous carriage of multiple pneumococcal serotypes in African children.Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.Early antiretroviral therapy improves neurodevelopmental outcomes in infants Immunogenicity of seven-valent pneumococcal conjugate vaccine administered at 6, 14 and 40 weeks of age in South African infants Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine.Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals.Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.Longitudinal developmental profile of children from low socio-economic circumstances in Cape Town, using the 1996 Griffiths Mental Development Scales Pneumococcal Acquisition Among Infants Exposed to HIV in Rural Malawi: A Longitudinal Household Study.Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life.High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants.HIV-associated CD4+/CD8+ depletion in infancy is associated with neurometabolic reductions in the basal ganglia at age 5 years despite early antiretroviral therapy HIV-Exposed Uninfected Infants Show Robust Memory B-Cell Responses in Spite of a Delayed Accumulation of Memory B Cells: an Observational Study in the First 2 Years of Life.Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy.Early Antiretroviral Therapy in HIV-Infected Children Is Associated with Diffuse White Matter Structural Abnormality and Corpus Callosum Sparing.Vaccination with 10-valent pneumococcal conjugate vaccine in infants according to HIV status.Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs.Pneumococcal immunization in immunocompromised hosts: where do we stand?PCVs in individuals at increased risk of pneumococcal disease: a literature review.Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study.Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.White Matter Abnormalities in Children with HIV Infection and Exposure.Use of Multiplex Quantitative PCR To Evaluate the Impact of Pneumococcal Conjugate Vaccine on Nasopharyngeal Pneumococcal Colonization in African Children.Altered brain morphometry in 7-year old HIV-infected children on early ART.Larger Subcortical Gray Matter Structures and Smaller Corpora Callosa at Age 5 Years in HIV Infected Children on Early ART.Functional Connectivity Alterations between Networks and Associations with Infant Immune Health within Networks in HIV Infected Children on Early Treatment: A Study at 7 Years.The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.Five year neurodevelopment outcomes of perinatally HIV-infected children on early limited or deferred continuous antiretroviral therapy.

P2860

Q26742161-7400DF92-B52A-42A5-9651-4F21A4B4B2A5 Q28088507-A29B457A-2C1A-45C7-8FEA-26C833D3E597 Q29999998-6AF7C4A9-2031-494B-840F-5E99E62CE1A7 Q30235055-B3CC1C10-C9EF-47B6-8EFC-8294195F594A Q30978868-D65E2D56-1D74-4791-B51B-F206CDC99E54 Q33741026-1804799C-71CB-4E30-A30C-039911D6F3D7 Q33763802-8EBB8F87-B70A-4A06-91D3-2E4B09085B6E Q33875478-AB7E1898-69C2-48C2-B5BE-717629FB7ADD Q34087769-F3A6ED03-B0CA-4EDE-91F6-AA10E9CF1F3C Q34093261-3C29F4B2-3532-40F5-94B8-4934BA5A9BA7 Q34981631-A94ABBE4-F51E-4417-AAA2-017A5D9EC66F Q35199219-04A654B6-AA34-40DB-90BC-EDD83F32ED1C Q35621571-CF9A48DC-9C8D-4B10-A082-71887FA68F8F Q35999709-611D2444-3424-4DB3-BED1-53910EB68EF7 Q36009704-76D73B23-0CCC-4B73-AE5F-ED508B3ACD1B Q36210265-E063B5F5-9FCA-4E0E-893B-AD35EAF835B0 Q36227731-64231AF0-D278-4976-853C-A1E73FA29C58 Q36402435-A54B9141-E04D-4C14-80C0-D437E73A38EE Q36504806-CEBD2DDD-5E45-4113-A28F-8FEB3F99488B Q36646867-5B7CB23B-126D-49F4-9693-B73FB4B47101 Q36822003-33D9714A-BA5A-475D-98BE-C0E82F78E3A6 Q36892965-B042CE79-D163-41CD-A6A3-85FBC0DBD199 Q37067271-54464CD0-2D2F-499C-B5C3-E090E3EFDD46 Q37302272-C85B9313-7119-4B32-B027-2C45B0307E43 Q37510621-5F319AC3-2FB0-4650-A952-95E478D6D631 Q37606399-22B002F8-44C1-4A24-9F04-2806CDE1792E Q37683620-6F291577-A4E1-40FD-B65F-B40C8A1894D1 Q38168902-1362E841-C1E6-42BD-B70C-C638A0AEC0B3 Q38530267-E554F930-4133-4025-A2D6-FE216640ACEC Q40529372-592D29F0-F0C9-445D-9198-38C486E947CB Q40722616-41CF3E05-189D-4172-99BB-75646C45BECC Q41489687-B2468D12-1741-4EFD-8A4B-5215ED86EF2F Q41505058-A2FA2A3F-A969-444E-821A-10DD4CAFC75D Q42369968-6FCCFBF4-B12E-4BE9-9E02-2B6CE5F9F7A7 Q44521723-8BB456D8-AB7D-4419-9C34-7242D528028F Q46724981-A1E2B2E1-6BBA-44E0-AE46-6E31954DA95A Q47201399-F3516037-B3B4-4AFE-A45D-5F3C999039F2 Q47555789-274EA23D-0D04-4923-9F68-F73746C2C53F Q52649837-1AF3236B-96A5-4966-9F09-DF86CE72A548 Q53686613-A2C6F8C1-0245-40CA-B670-C3B924C6EDE2

P2860

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

http://www.wikidata.org/entity/Q33988269

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effect of HIV infection status ...... l conjugate vaccine in infants

@ast

Effect of HIV infection status ...... l conjugate vaccine in infants

@en

type

label

Effect of HIV infection status ...... l conjugate vaccine in infants

@ast

Effect of HIV infection status ...... l conjugate vaccine in infants

@en

prefLabel

Effect of HIV infection status ...... l conjugate vaccine in infants

@ast

Effect of HIV infection status ...... l conjugate vaccine in infants

@en

P1433

Q33988269-590AC3E3-8212-4D54-AAB3-CE40A84F6E42

P1476

Q33988269-BA91BF12-3D89-4DAE-99AA-C728F0C18177

P2093

Q33988269-037B773F-A550-49BB-BEF0-27B188F6D713

Q33988269-7B8E7921-EDC0-4C25-A8FE-890FB8B42BF0

Q33988269-7C2585A4-B772-4971-AAD1-5FAF69A6A919

Q33988269-7D700DFE-A4A9-437E-B347-592E59A3D7E7

Q33988269-96524A03-D5B8-4E2D-A378-AEFDC3D36C1A

Q33988269-99A88FA6-63C6-4540-8506-F3DE0CECD275

Q33988269-CDDBA7F0-1771-4098-9B0E-8EC9CF05386B

Q33988269-D88CFDB2-FE62-4922-B52C-BEAA245F18E0

Q33988269-F7F68381-B1BC-448F-B2DF-87D0C3D2BD83

P2860

Q33988269-0344656D-1BCD-4C1C-8B96-F6BAE572C7D8

Q33988269-0F1C58EF-03D9-4A03-807A-D54D787E463D

Q33988269-1ACFCCD9-BE49-44B3-8D96-0AA46A4CC718

Q33988269-3DB43E31-B100-4E2E-BC63-DCA17D9AA06B

Q33988269-49ADE6DD-E1C3-49D3-A7A9-450959685BD7

Q33988269-55D0941B-8D5A-42C4-BA70-A2AFA574E9C0

Q33988269-5C79155E-D623-4022-8A85-9C4C908C6AFA

Q33988269-6A293AA4-7461-42EA-B7D2-B01EA2C8D2FC

Q33988269-8F29038A-BC90-4C63-B2B2-816F707433C8

Q33988269-DFEAA0A6-45F7-40AB-8C8D-C3BC028A346C

P304

Q33988269-1220D72F-8134-4E93-B825-3B10118C25F6

P31

Q33988269-F19918DD-5E59-4B7F-B056-DCA9B69E1BF4

P356

Q33988269-6B85CF7C-4A10-4638-A369-C1D4EBC49157

P407

Q33988269-09091ED4-C21E-4441-AAEA-9BE11526399B

P433

Q33988269-E669408E-F782-47ED-B213-D9ABD761932A

P478

Q33988269-2D73CFC7-CDFA-471D-9334-396FB9809530

P50

Q33988269-775E951C-41E0-4019-825C-6446E3F9BFC2

Q33988269-ADDC05E7-53CC-4768-BEEC-7704916F2DE9

P577

Q33988269-66EA12F4-192C-49BE-9B3F-0713CBCDE555

P5875

Q33988269-E04EFA0D-DAA2-4AF2-9E13-CDD61739BA08

P698

Q33988269-6353360D-4F08-4C1E-974F-135C2CD69F47

P921

Q33988269-9C49B59A-C045-4A65-901D-26CB1B9E8DE7

P932

Q33988269-6F9ACB0E-1365-4A56-9F83-872EF49BE592

P356

P1433

The Journal of Infectious Diseases

P1476

Effect of HIV infection status ...... l conjugate vaccine in infants

@en

P2093

Avye Violari

http://www.w3.org/2001/XMLSchema#string

Comprehensive International Program of Research on AIDS 4 Study Team

http://www.w3.org/2001/XMLSchema#string

Helena Käyhty

http://www.w3.org/2001/XMLSchema#string

James A McIntyre

http://www.w3.org/2001/XMLSchema#string

Mark F Cotton

http://www.w3.org/2001/XMLSchema#string

Patrick Jean-Philippe

http://www.w3.org/2001/XMLSchema#string

Peter Adrian

http://www.w3.org/2001/XMLSchema#string

Sharon Nachman

http://www.w3.org/2001/XMLSchema#string

Shawn Meadows

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine.

An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.

Early antiretroviral therapy and mortality among HIV-infected infants

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.

Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.

Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.

Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.

P304

355-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/653704

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

202

http://www.w3.org/2001/XMLSchema#string

P50

Shabir A. Madhi

Keith P. Klugman

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44805626

http://www.w3.org/2001/XMLSchema#string

P698

20583920

http://www.w3.org/2001/XMLSchema#string

P921

P932

2902789

http://www.w3.org/2001/XMLSchema#string